These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 28404964)

  • 21. A panel of microRNA signature in serum for colorectal cancer diagnosis.
    Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
    Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
    Lv ZC; Fan YS; Chen HB; Zhao DW
    Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum level of miR-142-3p predicts prognostic outcome for colorectal cancer following curative resection.
    Gao W; Pang D; Yu S
    J Int Med Res; 2019 May; 47(5):2116-2125. PubMed ID: 30922137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of miR-1228-3p as Housekeeping for MicroRNA Analysis in Liquid Biopsies from Colorectal Cancer Patients.
    Duran-Sanchon S; Vila-Navarro E; Marcuello M; Lozano JJ; Muñoz J; Cubiella J; Diez MS; Bujanda L; Lanas A; Jover R; Hernández V; Quintero E; Herreros-Villanueva M; Martín AC; Pérez-Palacios R; Arroyo R; Castells A; Gironella M
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31877644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma.
    Fang Z; Tang J; Bai Y; Lin H; You H; Jin H; Lin L; You P; Li J; Dai Z; Liang X; Su Y; Hu Q; Wang F; Zhang ZY
    J Exp Clin Cancer Res; 2015 Aug; 34(1):86. PubMed ID: 26297223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
    Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
    Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating miR-338-5p is a potential diagnostic biomarker in colorectal cancer.
    Bilegsaikhan E; Liu HN; Shen XZ; Liu TT
    J Dig Dis; 2018 Jul; 19(7):404-410. PubMed ID: 29952077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum
    Wang N; Zeng L; Li Z; Zhen Y; Chen H
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2650-2653. PubMed ID: 31240955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
    Li L; Wang A; Cai M; Tong M; Chen F; Huang L
    Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum miR-20a and miR-486 are potential biomarkers for discriminating colorectal neoplasia: A pilot study.
    Yang Q; Wang S; Huang J; Xia C; Jin H; Fan Y
    J Cancer Res Ther; 2018; 14(7):1572-1577. PubMed ID: 30589041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
    Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS
    Oncology; 2019; 97(3):173-179. PubMed ID: 31216561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer.
    Luo X; Wu Y; Ji M; Zhang S
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-223 and microRNA-92a in stool and plasma samples act as complementary biomarkers to increase colorectal cancer detection.
    Chang PY; Chen CC; Chang YS; Tsai WS; You JF; Lin GP; Chen TW; Chen JS; Chan EC
    Oncotarget; 2016 Mar; 7(9):10663-75. PubMed ID: 26848774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Potentials of miR-576-3p, miR-613, NDRG2 and YKL40 in Colorectal Cancer Patients.
    Eldaly MN; Metwally FM; Shousha WG; El-Saiid AS; Ramadan SS
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1689-1695. PubMed ID: 32592365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential value of miR-1 and miR-374b as biomarkers for colorectal cancer.
    Wu X; Li S; Xu X; Wu S; Chen R; Jiang Q; Li Y; Xu Y
    Int J Clin Exp Pathol; 2015; 8(3):2840-51. PubMed ID: 26045793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upregulation of serum miR-103 predicts unfavorable prognosis in patients with colorectal cancer.
    Wang DS; Zhong B; Zhang MS; Gao Y
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4518-4523. PubMed ID: 30058684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.